Background
==========

The cross-sectional nature of our previous study by late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) in systemic right ventricle (RV) patients limited our ability to make conclusions about the prognostic predictive value of LGE in this population. Therefore, we performed this larger prospective study to determine whether fibrosis detected by LGE CMR would predict adverse outcomes in patients treated for transposition of the great arteries by atrial redirection surgery with RV in the systemic position and at risk of arrhythmia, premature RV failure, and sudden death.

Methods
=======

Fifty-five patients (aged 27±7 years) underwent LGE CMR and were followed for a mean of 6.5±3.2 years in a single-centre study. The pre-specified composite clinical endpoint consisted of new-onset sustained atrial/ventricular tachyarrhythmia or decompensated heart failure admission/transplantation/death.

Results
=======

RV LGE was present in 31 (56%) patients. In 8 out of 9 (89%) patients with more than one event, atrial tachyarrhythmia, itself a known risk factor for mortality, occurred first. Univariate predictors of the composite endpoint (n=22 patients; 19 atrial/2 ventricular tachyarrhythmia, 1 death) included RV LGE presence and extent, RV volumes/mass/ejection fraction, right atrial area, peak VO~2~ and age at repair. In bivariate analysis, RV LGE presence was independently associated with the composite endpoint, and remained significant (hazard ratio (HR) 4.95\[95% confidence interval (CI) 1.60-15.28\],p=0.005) when compared with the second independent predictor, percent predicted peak VO~2~ (HR 0.80\[95% CI 0.68-0.95\],p=0.009 per 5%). When fibrosis status was added to peak VO~2~%, risk prediction for cardiac events was further refined.

There was clear agreement between location and extent of RV LGE at *in vivo* CMR and histologically documented focal RV fibrosis in an explanted heart from one of the study patients. Lastly, RV LGE appeared progressively extended in another patient from our cohort restudied for clinical indication.

Conclusions
===========

LGE in the systemic RV was commonly found in our cohort of adult patients late after atrial redirection surgery for transposition of the great arteries and is a strong and independent predictor of adverse clinical outcome. RV LGE should therefore be incorporated in risk stratification for adverse cardiac outcomes in these patients.
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